Indian doctors hail diabetes breakthrough
Wednesday 14 July 2010
Indian scientists said Tuesday they had made a breakthrough that could lead to diabetics needing to inject themselves only once a month or less, rather than every day.
Researchers at the National Institute of Immunology in New Delhi said they had successfully concluded a two-year trial on mice, rats and rabbits of a drug which slowly releases insulin into the body over weeks or even months.
Reporting in the US journal Proceedings of the National Academy of Sciences (PNAS), they said a single dose of the drug - SIA-II - was able to maintain a minimum level of insulin in a rat for more than 120 days.
"I think this is a very exciting development," Anoop Misra, director of the diabetes department at Fortis Hospitals in New Delhi, and chairman of the Diabetes Foundation (India), told AFP.
Misra said once-a-week injections for diabetes were making good progress in trials but that monthly injections were pioneering territory.
"This longer control of diabetes with a single reservoir of insulin is entirely new, though one must keep in mind this has been done just in animal models," he said of the prototype drug.
"It is still in the early stages of development."
Avadhesha Surolia, director of the National Institute of Immunology and one of the paper's authors, told the Mint newspaper that the technology had been licensed to Life Science Pharmaceuticals in Connecticut.
He described the agreement as "one of the biggest licensing deals from any academic institution in India."
More than 220 million people worldwide suffer from diabetes, which kills more than one million people each year, according to the World Health Organization (WHO).
The illness is affecting a growing number of people across Asia because of a combination of modern diets, increasingly urban living and genetics.
Some diabetics have to inject insulin every few hours and must carefully watch their diet and blood sugar levels because their bodies are unable to break down glucose in the blood.
interviewThe producer and activist, Trudie Styler, whose film 'Filth' is up for five film awards, is tapping into the industry's neglected female talent
musicBlack Sabbath have pulled off one of rock music’s great comebacks – against all odds
interviewHer estate has become the nation's glossiest food empire
theatreTheatre's hitmaker Daniel Evans on 'Oliver' and bringing 'The Full Monty' to the stage
food + drinkMichelin-starred Tom Sellers on being this year's hottest property
tvParents (and kids) rejoice! A new wave of fantastic family entertainment is here
booksGeese, gorillas, grandads... and growing up
food + drinkHow one grocery e-tailer is gearing up for the Yuletide rush
food + drink
travelFor broadcaster Mishal Husain, a long-haul Club Med holiday was a chance for her family to explore its sense of 'zen' and 'animation'
food + drinkFestive snacks don't have to be fiddly, says Bill Granger
Life & Style blogs
- 1 Hundreds arrested as Canadian police smash worldwide paedophile ring
- 2 Sherlock series 3: Benedict Cumberbatch and Martin Freeman provide teasers for the biggest comeback in British television
- 3 Why Barcelona chose Everton to educate their latest prodigy
- 4 Mass murder in the Middle East is funded by our friends the Saudis
- 5 Japan cracks down on leaks after scandal of Fukushima nuclear power plant
- < Previous
- Next >
£30000 - £45000 per annum + Benefits: Harrington Starr: C# .NET Server Side De...
£50000 - £60000 per annum + Benefits: Harrington Starr: C# ASP.NET Developer (...
£60000 - £65000 per annum + Benefits: Harrington Starr: Senior C# WPF .NET Dev...
Negotiable: Harrington Starr: QA Manual Tester FX Trading Platform/Derivative...